Predicting factors linked to severity and disease duration in children with chronic urticaria

N.A. Sinelnikova 1, N.M. Kalinina 2, N.D. Savenkova 1, N.V. Bychkova 2

1 State budget institution of higher professional education «Saint-Petersburg State Pediatric Medical University» Ministry of Health of the Russian Federation, Saint-Petersburg, Russia
2 All-Russian Center of Extreme and Radiation Medicine, Russian Ministry of Extreme Situation, Saint-Petersburg, Russia

ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS, Volume 53 • Number 2 • June 2018, pp. 32 – 40
DOI: 10.24411/2500-1175-2018-00010

Were studied clinical and immunological markers of severity and duration of the disease, using the weekly scale of activity of CU- UAS7 (UAS7-urticaria activity score, 7 days) in order to verify the features of chronic urticaria (СU) in children. This study revealed some clinical and immunological characteristics of CU in children with varying severity (activity) and duration of the disease. It is found that increasing the number of activated basophiles (Ваt-203c++), activation of the complement system (increase of level of С3а, С1іпһ) are not favorable laboratory markers indicating longer periods of illness and expressed activity of the CU. Laboratory markers of patients sensitive and refractory to antihistamine (AH) therapy were determined (the elevation of total IgE and С3а in sensitive to Н1-АН; normal values of total IgE and a significant increase of С3а in refractory to H1-AH patients). Was revealed the association between the activation of complement system, normal IgE values and the degree of CU activity in children with longer periods of the disease, refractory to AH therapy. Among the 65 children with CU, 32 (50%) achieved complete remission after 6 months – 1 year, 26 (40%) after 2 to 3 years, 7 (10%) retain episodic urticaria symptoms of varying intensity.

  1. Балаболкин И.И. Крапивница у детей: клинико-патогенетические варианты, диагностика и лечение // Российский педиатрический журнал. 2017. № 2. С. 122–128.
  2. Крапивница у детей: клинические рекомендации / А.А.Баранов, Л.С.Намазова-Баранова; Союз педиатров России, Министерство здравоохранения Российской Федерации. 2016.
  3. Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review P.Kolhir, E.Borzova, C.Grattan et al.// J. Autoimmunity Reviews. 2017. Vol. 16. P. 1196–1208.
  4. Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study / K.Hollis, C.Proctor, D.McBride et al. // Am. J. Clin. Dermatol. 2018. Vol. 18. P. 1–8.doi: 10.1007/s40257-017-0331-8.
  5. The EAACI/GA²LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update / T.Zuberbier, W.Aberer, R. Aseroet al. // А 2018. doi: 10.1111/all.13397.
  6. Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria / M.Sanchez-Borges, F.Caballero-Fonseca, A.Capriles-Hulettet al. // Eur. Acad. Dermatol. Venereol. 2017. Vol. 31. P. 964–971.
  7. Кудрявцева А.В., Нескородова К.А. Крапивница у детей: патогенетические механизмы и возможности современной терапии // Вестник дерматологии и венерологии. 2017. № 2. С. 73–82.
  8. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease / H.J.Hoffmann, A.F.Santos, C. Mayorga et al. // Allergy. 2015. Vol. 70. P. 1393–1405.
  9. Autologous Serum and Plasma Skin Tests in Chronic Spontaneous Urticaria: A Reappraisal / M.S.Kumaran, S.Mangal, T. Naranget al.// Indian Dermatol. Online J. 2017. Vol. 8. P. 94–99.
  10. Pathophysiology of urticaria / A.Nosbaum, F.Augey, J.-F.Nicolas et al. // Annales de dermatologieet de venerologie. 2014. Vol. 141. P. 559–564.
  11. Колхир П.В., Олисова О.Ю., Кочергин Н.Г. Эндотипическая классификация хронической спонтанной крапивницы – путь к персонифицированной терапии // Лечащий врач. 2015. № 5. С. 45.
  12. Self-reactive IgE exacerbates interferon responses associated with autoimmunity / J.Henault, J.M.Riggs, J.L.Karnell et al. // Nat. Immunol. 2016. Vol. 17. P. 196–203.
  13. Association betweenurticaria and virus infections: A systematic review / E.Imbalzano, M.Casciaro, S.Quartuccioet al. // Allergy and astma proceedings.  Vol. 35. P. 295–302.
  14. Wu E.Y.,Saini S.S. Chronic Idiopathic Urticaria // Allergy Clin. Immunol. Pract. 2015. Vol. 3. P. 1003–1014.
  15. Lucerna A.R., Espinosa J., Darlington A.M. Methicillin-resistant Staphylococcus Aureus Lip Infection Mimicking Angioedema // Emerg. Med. 2015. Vol. 49. P. 8–11.
  16. Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria/ J.Graham, D.McBride, D.Stull et al. // Pharmacoeconomics. 2016. Vol. 34. P. 815–827.
  17. An individualized diagnostic approach based on guidelines for chronic urticaria (CU) / A.M.Giménez-Arnau, C.Grattan, T. Zuberbieret al.// Journal of the European Academy of Dermatology and Venereology. 2015. Vol. 29. P. 3–11.
  18. Борзова Е.Ю., Салугина С.О. Актуальные вопросы дифференциальной диагностики крапивницы // Эффективная фармакотерапия. 2017. № 7. С. 34–45.
  19. Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders / C.B.Cho, S.A.Stutes, M.L. Altrich et al. // Ann. Allergy Asthma 2013. Vol. 110. P. 29–33.
  20. Characteristic of basophil activation in children with spontaneous and inducible urticaria / N.A.Sinelnikova, N.D.Savenkova, N.M. Kalinina et al. // Allergy, Asthma and Immunophysiology: Innovative Technologies. 2016. Filodiritto International Proceedings. P. 65–72.
  21. Синельникова Н.А., Калинина Н.М., Савенкова Н.Д. Особенности системы комплемента у детей с хронической крапивницей // Российский вестник перинатологии и педиатрии. 2016. № 4. С. 98–103.
  22. Динамика течения хронической спонтанной крапивницы у больных с атопическими и другими коморбидными заболеваниями / А.В.Витчук, Р.Я.Мешкова, Н.В. Ковригина и др. // Вестник Смоленской государственной медицинской академии. 2016. Том 15,№ 3. С. 52–56.

Sinelnikova NA, Kalinina NM, Savenkova ND, Bychkova NV. Predicting factors linked to severity and disease duration in children with chronic urticaria. Allergology and Immunology in Pediatrics. 2018;53(2):32-40. (In Russ.) https://doi.org/10.24411/2500-1175-2018-00010

For correspondense

N.A. Sinelnikova
e-mail: N_Sinelnikova@mail.ru

N.M. Kalinina
e-mail: Doctkalin@mail.ru

N.D. Savenkova
e-mail: Savenkova.n.spb@mail.ru

N.V. Bychkova
e-mail: BNV19692007@yandex.ru

ALLERGOLOGY and IMMUNOLOGY in PEDIATRICS

Spelling error report

The following text will be sent to our editors: